|
Cyclacel Agrees to Sell Patents to Celgene; Litigation to Be Dismissed
|
7:45 AM |
Apr 4, 2013 |
Dow Jones Global News Select
|
|
Celgene Corporation to Announce First Quarter 2013 Results on April 25, 2013
|
7:30 AM |
Apr 3, 2013 |
PR
|
|
The Vatican's Pontifical Council for Culture, -2-
|
8:56 AM |
Mar 22, 2013 |
PR
|
|
The Vatican's Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Announce Highlights of the Upcoming Second International Adult Stem Cell Conference
|
8:56 AM |
Mar 22, 2013 |
PR
|
|
Amarin, Celgene, GlaxoSmithKline, Spectrum Pharma, and Geron Briefing and Review
|
12:22 PM |
Mar 18, 2013 |
PR
|
|
Upcoming Results from Clinical Trials - Research Report on Gilead Sciences, Celgene Corporation, Sinovac Biotech, NPS Pharmaceuticals and ZIOPHARM Oncology
|
8:00 AM |
Mar 18, 2013 |
PR
|
|
UPDATE: Onyx Pharmaceuticals CEO: Seeking Acquisition Targets
|
3:36 PM |
Mar 15, 2013 |
Dow Jones Global News Select
|
|
Onyx Pharmaceuticals CEO: Seeking Acquisition Targets
|
12:25 PM |
Mar 15, 2013 |
Dow Jones Global News Select
|
|
A Forward Look, The Year Ahead - Research Report on Kellogg Company, General Mills, Inc., Gilead Sciences, Inc., Celgene Corporation and The Coca-Cola Company
|
8:01 AM |
Mar 13, 2013 |
PR
|
|
Drug Approvals, Breakthrough Treatments and Royalties - Research Report on Celgene Corporation, Onyx Pharmaceuticals, Sarepta Therapeutics, VIVUS and Achillion Pharmaceuticals
|
8:01 AM |
Mar 8, 2013 |
PR
|
|
Celgene Drug Results Fall Short of Earlier Trial
|
12:49 PM |
Mar 2, 2013 |
WSJ.com
|
|
Research Reports
|
2:52 PM |
Mar 4, 2013 |
Barrons.com
|
|
Don't Sell Celgene
|
1:46 PM |
Feb 11, 2013 |
Barrons.com
|
|
Stocks to Watch: Novo Nordisk, US Airways, Radian Group
|
9:18 AM |
Feb 11, 2013 |
WSJ.com
|
|
Stocks Finish Down; Celgene, Herbalife Gain
|
5:08 PM |
Jan 8, 2013 |
Barrons.com
|
|
Celgene Shares Rose 4.4% on Big Hopes for 2017
|
4:42 PM |
Jan 7, 2013 |
Barrons.com
|
PLAY
PLAY
